Loading data
BDTXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 33.56 m USD | 51.31 m USD | 59.35 m USD | 64.44 m USD | 96.83 m USD |
| Operating profit | 12.52 m USD | -78.78 m USD | -86.46 m USD | -92.83 m USD | -126.87 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | 22.37 bn USD | -69.68 bn USD | -82.44 m USD | -91.17 m USD | -125.6 m USD |
| Basic earnings per share | 0.39 USD/share | -1.27 USD/share | -1.88 USD/share | -2.52 USD/share | -3.47 USD/share |
| Diluted earnings per share | 0.39 USD/share | -1.27 USD/share | -1.88 USD/share | -2.52 USD/share | -3.47 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.